» Articles » PMID: 26429318

Frequent IgG Subclass and Mannose Binding Lectin Deficiency in Patients with Chronic Fatigue Syndrome

Overview
Journal Hum Immunol
Date 2015 Oct 3
PMID 26429318
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

Chronic fatigue syndrome (CFS) is a severe disease characterized by various symptoms of immune dysfunction. CFS onset is typically with an infection and many patients suffer from frequently recurrent viral or bacterial infections. Immunoglobulin and mannose binding lectin (MBL) deficiency are frequent causes for increased susceptibility to infections. In this study we retrospectively analysed 300 patients with CFS for immunoglobulin and MBL levels, and B-cell subset frequencies. 25% of the CFS patients had decreased serum levels of at least one antibody class or subclass with IgG3 and IgG4 subclass deficiencies as most common phenotypes. However, we found elevated immunoglobulin levels with an excess of IgM and IgG2 in particular in another 25% of patients. No major alteration in numbers of B cells and B-cell subsets was seen. Deficiency of MBL was found in 15% of the CFS patients in contrast to 6% in a historical control group. In a 2nd cohort of 168 patients similar frequencies of IgG subclass and MBL deficiency were found. Thus, humoral immune defects are frequent in CFS patients and are associated with infections of the respiratory tract.

Citing Articles

Clinical and Diagnostic Features of Post-Acute COVID-19 Vaccination Syndrome (PACVS).

Mundorf A, Semmler A, Heidecke H, Schott M, Steffen F, Bittner S Vaccines (Basel). 2024; 12(7).

PMID: 39066428 PMC: 11281408. DOI: 10.3390/vaccines12070790.


Data-independent LC-MS/MS analysis of ME/CFS plasma reveals a dysregulated coagulation system, endothelial dysfunction, downregulation of complement machinery.

Nunes M, Vlok M, Proal A, Kell D, Pretorius E Cardiovasc Diabetol. 2024; 23(1):254.

PMID: 39014464 PMC: 11253362. DOI: 10.1186/s12933-024-02315-x.


[Interdisciplinary, collaborative D-A-CH (Germany, Austria and Switzerland) consensus statement concerning the diagnostic and treatment of myalgic encephalomyelitis/chronic fatigue syndrome].

Hoffmann K, Hainzl A, Stingl M, Kurz K, Biesenbach B, Bammer C Wien Klin Wochenschr. 2024; 136(Suppl 5):103-123.

PMID: 38743348 PMC: 11093804. DOI: 10.1007/s00508-024-02372-y.


Advancing Research and Treatment: An Overview of Clinical Trials in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and Future Perspectives.

Seton K, Espejo-Oltra J, Gimenez-Orenga K, Haagmans R, Ramadan D, Mehlsen J J Clin Med. 2024; 13(2).

PMID: 38256459 PMC: 10816159. DOI: 10.3390/jcm13020325.


Immunological Patient Stratification in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Rohrhofer J, Hauser L, Lettenmaier L, Lutz L, Koidl L, Gentile S J Clin Med. 2024; 13(1).

PMID: 38202282 PMC: 10779792. DOI: 10.3390/jcm13010275.